0001209191-18-042041.txt : 20180709
0001209191-18-042041.hdr.sgml : 20180709
20180709181429
ACCESSION NUMBER: 0001209191-18-042041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180705
FILED AS OF DATE: 20180709
DATE AS OF CHANGE: 20180709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18945576
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2018-07-05
4
M
0
4250
122.45
A
43859
D
Common Stock
2018-07-05
4
S
0
4250
168.38
D
39609
D
Stock Option (Right to Buy)
122.45
2018-07-05
4
M
0
4250
0.00
D
2026-01-03
Common Stock
4250
25500
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 1/4/2016.
/s/ Stephen Migausky, Attorney-in-Fact
2018-07-09